Titre:
  • Early versus delayed treatment of relapsed ovarian cancer (MRC OV05/EORTC 55955): a randomised trial.
Auteur:van der Burg, Maria; Griffin, Clare L; Guthrie, David; Lamont, Alan; Jayson, Gordon C; Kristensen, Gunnar; Mediola, César; Coens, Corneel; Qian, Wendi; Parmar, Mahesh K B; Swart, Anne Marie; MRC OV05, Pascal; EORTC 55955 investigators, ; Rustin,
Informations sur la publication:Lancet, 376, 9747, page (1155-1163)
Statut de publication:Publié, 2010-10
Sujet CREF:Cancérologie
MeSH keywords:Adult
Aged
Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
CA-125 Antigen -- blood
Carcinoma -- diagnosis -- drug therapy -- immunology
Drug Administration Schedule
Early Detection of Cancer
Europe
Evidence-Based Medicine
Female
Follow-Up Studies
Humans
Kaplan-Meier Estimate
Middle Aged
Neoplasm Recurrence, Local -- diagnosis -- drug therapy -- immunology
Ovarian Neoplasms -- diagnosis -- drug therapy -- immunology
Platinum Compounds -- administration & dosage
Quality of Life
Questionnaires
Russia
South Africa
Time Factors
Treatment Outcome
Tumor Markers, Biological -- blood
Note générale:Comparative Study
Journal Article
Multicenter Study
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langue:Anglais
Identificateurs:urn:issn:0140-6736
info:doi/10.1016/S0140-6736(10)61268-8
info:pii/S0140-6736(10)61268-8
info:pmid/20888993